Patrick Krol is the Portfolio Manager and together with the Investment Team, he manages the investments of the Aescap funds. Privium Fund Management B.V. (Privium) is the Alternative Investment Fund Manager of the fund. The Fund Manager is responsible for the management of the fund per the provisions of the Fund Documents and applicable laws. Privium Fund Management B.V. is authorized and regulated by the Dutch Authority for the Financial Markets (www.afm.nl) as an Alternative Investment Fund Manager (AIFM) as referred to in article 2:65 (a). Both Privium and the funds are registered in the Register of AFM. Privium is a Fund Manager with offices in Amsterdam, London, Hong Kong and Singapore and focuses on alternative investments. As a group, Privium is managing over USD 3 billion. For additional information on the Fund Manager please visit Privium’s website.
Structure, service providers and governance
Both Aescap funds are funds for joint account, also known in Dutch as FGR (Fonds voor Gemene Rekening). They are tax transparent meaning they don’t pay corporate income tax. Stichting Aescap Life Sciences acts as the Legal Owner of the Aescap Life Sciences Fund. Stichting Aescap Genetics acts as the Legal Owner of the Aescap Genetics Fund. The Legal Owner’s statutory purpose is to act as Legal Owner of the investments of the Fund and to protect the interests of the investors as required by law. IQEQ Financial Services B.V has been appointed to provide certain financial, accounting, administrative and other services to the Fund. This includes the calculation of the Net Asset Value of the Fund, as well as, the participant administration. APEX Depositary Services has been appointed as Depositary and has the task to safeguard the interests of the investors of the Fund. The Depositary has delegated the safekeeping (custody) of the relevant Fund Assets to Saxo Bank.
List of involved parties